المؤلفون: Climent MÁ; Valencian Institute of Oncology, Valencia, Spain., Álvarez C; Hospital Universitario Central de Asturias, Oviedo, Spain., Morales R; Vall d'Hebron University Hospital, Barcelona, Spain., Maroto P; Hospital Universitari de La Santa Creu I Sant Pau, Barcelona, Spain., Rodríguez-Vida A; Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain., Méndez-Vidal MJ; Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital (HURS), Cordoba, Spain., Del Muro XG; Catalan Institute of Oncology, Barcelona, Spain., Puente J; Hospital Universitario Clínico San Carlos, Madrid, Spain., Láinez N; University Hospital of Navarra, Pamplona, Spain., Vázquez S; Hospital Universitario Lucus Augusti, Lugo, Spain., Castellano D; Hospital 12 de Octubre, Madrid, Spain., Lang CG; Merck S.L.U., an Affiliate of Merck KGaA, Madrid, Spain., Wang J; Pfizer, Cambridge, MA, USA., di Pietro A; Pfizer Srl, Milan, Italy., Davis C; Pfizer Translational Oncology, La Jolla, CA, USA., Sanz-Castillo B; Pfizer Oncology, Madrid, Spain., Bolós MV; Pfizer Oncology, Madrid, Spain., Valderrama BP; Virgen del Rocío University Hospital, Seville, Spain. bpvalderrama@gmail.com.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jun; Vol. 26 (6), pp. 1532-1538. Date of Electronic Publication: 2023 Dec 15.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen*/metabolism , Antibodies, Monoclonal, Humanized*/therapeutic use , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/metabolism , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/mortality , Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/metabolism , Carcinoma, Transitional Cell*/pathology, Humans ; Progression-Free Survival ; Female ; Male ; Antineoplastic Agents, Immunological/therapeutic use ; Aged ; Middle Aged ; Maintenance Chemotherapy ; Survival Rate

المؤلفون: Bellmunt J; Department of Medical Oncology, Beth Israel Deaconess Medical Center and IMIM-PSMAR Lab, Harvard Medical School, Boston, MA, USA., Valderrama BP; Department of Medical Oncology, Virgen del Rocío University Hospital, Sevilla, Spain., Puente J; Department of Medical Oncology, San Carlos Clinic University Hospital, San Carlos Health Research Institute, Madrid, Spain., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Bolós MV; Pfizer, Madrid, Spain., Lainez N; Department of Medical Oncology, Navarra University Hospital, Pamplona, Spain., Vázquez S; Department of Medical Oncology, Lucus Augusti University Hospital, Lugo, Spain., Maroto P; Department of Medical Oncology, Santa Creu and Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain., Climent MÁ; Department of Medical Oncology, Valencia Institute of Oncology Foundation, Valencia, Spain., Garcia Del Muro X; Department of Medical Oncology, Catalan Institute of Oncology, IDIBELL, University of Barcelona, Barcelona, Spain., Arranz JÁ; Department of Medical Oncology, Gregorio Marañón University Hospital, Madrid, Spain., Durán I; Department of Medical Oncology, Marqués de Valdecilla University Hospital, IDIVAL, Santander, Spain. Electronic address: ignaciojose.duran@scsalud.es.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Jun; Vol. 174, pp. 103683. Date of Electronic Publication: 2022 Apr 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/drug therapy , Urinary Bladder Neoplasms*/pathology, Disease Management ; Humans ; Immunotherapy ; Neoplasm Recurrence, Local

المؤلفون: Pinto Á; Medical Oncology Department, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046 Madrid, Spain. Electronic address: alvaropintomarin@gmail.com., Reig O; Medical Oncology Department, Hospital Clinic i Provincial, Carrer de Villarroel, 170, 08036 Barcelona, Spain., Iglesias C; Medical Oncology Department, Hospital Universitario Central de Asturias, Avenida Roma, s/n, 33011 Oviedo, Spain., Gallardo E; Medical Oncology Department, Hospital Universitario Parc Taulí de Sabadell, Parc Taulí, 1, 08208 Sabadell, Barcelona, Spain., García-Del Muro X; Medical Oncology Department, Institut Català d'Oncologia Hospitalet, IDIBELL Institute of Researh, University of Barcelona, 1, Avinguda de la Granvia de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain., Alonso T; Medical Oncology Department, Hospital Universitario Ramón y Cajal, M-607, km. 9, 100, 28034 Madrid, Spain., Anguera G; Medical Oncology Department, Nou Hospital De La Santa Creu i Sant Pau, Carrer de Sant Quintí, 89, 08041 Barcelona, Spain., Suárez C; Medical Oncology Department, Hospital Universitario Vall de Hebrón, Passeig de la Vall d'Hebron, 119, 08035 Barcelona, Spain., Muñoz-Langa J; Medical Oncology Department, Hospital Universitario La Fe, Avinguda de Fernando Abril Martorell, 106, 46026, Valencia, Spain., Villalobos-León L; Medical Oncology Department, Hospital Universitario Príncipe de Asturias, Carretera de Alcalá, s/n, 28805 Meco, Madrid, Spain., Rodríguez-Sánchez Á; Medical Oncology Department, Hospital Universitario de León, Calle Altos de Nava, s/n, 24071 León, Spain., Lainez N; Medical Oncology Department, Complejo Hospitalario de Navarra, Calle de Irunlarrea, 3, 31008 Pamplona, Spain., Martínez-Ortega E; Medical Oncology Department , Complejo Hospitalario de Jaén, Avenida del Ejército Español, 10, 23007 Jaén, Spain., Campayo M; Medical Oncology Department, Hospital Universitario MútuaTerrassa, Plaza del Doctor Robert, 5, 08221, Terrassa, Barcelona, Spain., Velastegui A; Medical Oncology Department, Hospital Universitario Rey Juan Carlos, Calle Gladiolo, s/n, 28933 Móstoles, Madrid, Spain., Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, Passeig Marítim 25-29, 08001, Barcelona, Spain., Villa-Guzmán JC; Medical Oncology Department, Hospital General Universitario de Ciudad Real General, Calle Obispo Rafael Torija, s/n, 13005 Ciudad Real, Spain., Méndez-Vidal MJ; Medical Oncology Department, Hospital Universitario Reina Sofía, Avenida Menendez Pidal, 14004, Córdoba, Spain., Rubio G; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Avenida Reyes Católicos, 2, 28040, Madrid, Spain., García I; Medical Oncology Department, Hospital Virgen de la Salud, Av. de Barber, 30, 45004 Toledo, Spain., Capdevila L; Medical Oncology Department, Hospital San Pablo y Santa Tecla, Rambla Vella, 14, 43003 Tarragona, Spain., Lambea J; Medical Oncology Department, Hospital Clínico Universitario Lozano Blesa, Avda, Calle de San Juan Bosco, 15, 50009 Zaragoza, Spain., Vázquez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Rúa Dr. Ulises Romero, 1, 27003 Lugo, Spain., Fernández O; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Calle Ramon Puga Noguerol, 54, 32005 Ourense, Spain., Hernando-Polo S; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Calle Budapest, 1, 28922, Alcorcón, Madrid, Spain., Cerezo S; Medical Oncology Department, Hospital General La Mancha Centro, Av. Constitución, 3, 13600 Alcázar de San Juan, Ciudad Real, Spain., Santander C; Medical Oncology Department, Hospital Universitario Miguel Servet, Paseo Isabel la Católica, 1-3, 50009 Zaragoza, Spain., García-Marrero R; Medical Oncology Department, Hospital Universitario de Canarias, Carretera Ofra S/N, 38320 San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain., Zambrana F; Medical Oncology Department, Hospital Universitario Infanta Sofía, Paseo de Europa, 34, 28703 San Sebastián de los Reyes, Madrid, Spain., González-Del Alba A; Medical Oncology Department, Hospital Universitari Son Espases, Carretera de Valldemossa, 79, 07120 Palma, Spain., Lazaro-Quintela M; Medical Oncology Department, Hospital Álvaro Cunqueiro, Estrada de Clara Campoamor, 341, 36213 Vigo, Spain., Castellano D; Medical Oncology Department, Hospital Universitario 12 de Octubre, Av. de Córdoba, s/n, 28041 Madrid, Spain., Chirivella I; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Av. de Blasco Ibáñez, 17, 46010 Valencia, Spain., Anido U; Medical Oncology Department, Hospital Clínico Universitario de Santiago de Compostela, Rúa da Choupana, s/n, 15706 Santiago de Compostela, A Coruña, Spain., Viana A; Medical Oncology Department, Hospital Nuestra Señora del Prado, Carretera de Madrid Km. 114, 45600 Talavera de la Reina, Toledo, Spain., García A; TFS Trial Form Support S.L., Passeig de Gràcia, 11, 08007 Barcelona, Spain., Sotelo M; Medical Oncology Department, Hospital Universitario Infanta Cristina, Av. 9 de Junio, 2, 28981 Parla, Madrid, Spain., Arévalo MG; Medical Oncology Department, Hospital Universitario Severo Ochoa, Av. de Orellana, s/n, 28911 Leganés, Madrid, Spain., García-Donas J; Medical Oncology Department, Hospital Universitario Clara Campal, Calle de Oña, 10, 28050 Madrid, Spain., Hernández C; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Ctra. Gral. del Rosario, 145, 38010 Santa Cruz de Tenerife, Spain., Bolós MV; Pfizer S.L.U. Avenida de Europa, 20, 28108, Madrid, Spain., Llinares J; Pfizer S.L.U. Avenida de Europa, 20, 28108, Madrid, Spain., Climent MA; Medical Oncology Department, Instituto Valenciano De Oncología, Carrer del Professor Beltrán Báguena, 8, 46009 Valencia, Spain.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Feb; Vol. 20 (1), pp. 25-34. Date of Electronic Publication: 2021 Oct 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/pathology, Axitinib/therapeutic use ; Female ; Humans ; Male ; Retrospective Studies ; Sunitinib

المؤلفون: Castellano D; a Hospital Universitario 12 de Octubre , Madrid , Spain., Maroto JP; b Medical Oncology , Hospital de la Santa Creu i Sant Pau , Barcelona , Spain., Espinosa E; c Hospital Universitario La Paz , Madrid , Spain., Grande E; d Ramón y Cajal University Hospital , Madrid , Spain., Bolós MV; e Pfizer , Madrid , Spain., Llinares J; e Pfizer , Madrid , Spain., Esteban E; f General University Hospital of Asturias , Asturias , Spain., González Del Alba A; g Hospital Universitario Son Espases , Palma de Mallorca , Spain., Climent MA; h Instituto Valenciano de Oncología , Valencia , Spain., Arranz JA; i Hospital General Universitario Gregorio Marañón , Madrid , Spain., Méndez MJ; j Medical Oncology , Hospital Universitario Reina Sofia , Córdoba , Spain., Fernández Parra E; k Hospital de Valme , Sevilla , Spain., Antón-Aparicio L; l Juan Canalejo University Hospital , La Coruña , Spain., Bayona C; m Hospital General Yague , Burgos , Spain., Gallegos I; n Hospital de Segovia , Spain., Gallardo E; o Parc Taulí Hospital Universitari , Sabadell , Spain., Samaniego L; p Trial Form Support , Madrid , Spain., García Donas J; q 17HM Hospitales, Centro Integral Oncológico HM Clara Campal , Madrid , Spain.

المصدر: Expert opinion on drug safety [Expert Opin Drug Saf] 2018 Jun; Vol. 17 (6), pp. 573-579. Date of Electronic Publication: 2017 Aug 28.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Carcinoma, Renal Cell/*drug therapy , Indoles/*administration & dosage , Kidney Neoplasms/*drug therapy , Pyrroles/*administration & dosage, Angiogenesis Inhibitors/administration & dosage ; Angiogenesis Inhibitors/adverse effects ; Antineoplastic Agents/adverse effects ; Carcinoma, Renal Cell/pathology ; Disease-Free Survival ; Humans ; Indoles/adverse effects ; Kidney Neoplasms/pathology ; Neoplasm Metastasis ; Pyrroles/adverse effects ; Randomized Controlled Trials as Topic ; Spain ; Sunitinib ; Survival Rate ; Treatment Outcome

المؤلفون: Zahonero C; Neuro-Oncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain., Aguilera P; Neuro-Oncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain., Ramírez-Castillejo C; Neuro-Oncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain., Pajares M; Neuro-Oncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain., Bolós MV; Pfizer Oncology, Madrid, Spain., Cantero D; Unidad Multidisciplinar de Neurooncología, Hospital Universitario 12 de Octubre, Madrid, Spain., Perez-Nuñez A; Unidad Multidisciplinar de Neurooncología, Hospital Universitario 12 de Octubre, Madrid, Spain., Hernández-Laín A; Unidad Multidisciplinar de Neurooncología, Hospital Universitario 12 de Octubre, Madrid, Spain., Sánchez-Gómez P; Neuro-Oncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain. juanmanuel.sepulveda@salud.madrid.org psanchezg@isciii.es., Sepúlveda JM; Unidad Multidisciplinar de Neurooncología, Hospital Universitario 12 de Octubre, Madrid, Spain. juanmanuel.sepulveda@salud.madrid.org psanchezg@isciii.es.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2015 Jul; Vol. 14 (7), pp. 1548-58. Date of Electronic Publication: 2015 May 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Xenograft Model Antitumor Assays*, ErbB Receptors/*antagonists & inhibitors , Glioblastoma/*drug therapy , Quinazolinones/*pharmacology, Animals ; Blotting, Western ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Gene Amplification ; Glioblastoma/genetics ; Glioblastoma/metabolism ; Humans ; Mice, Nude ; Phosphorylation/drug effects ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction/drug effects ; Survival Analysis ; Time Factors ; Tumor Burden/drug effects ; Tumor Burden/genetics ; Tumor Cells, Cultured

المؤلفون: Gámez-Pozo A; Laboratory of Molecular Oncology and Pathology, Instituto de Genética Médica y Molecular (INGEMM), Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain., Antón-Aparicio LM, Bayona C, Borrega P, Gallegos Sancho MI, García-Domínguez R, de Portugal T, Ramos-Vázquez M, Pérez-Carrión R, Bolós MV, Madero R, Sánchez-Navarro I, Fresno Vara JA, Espinosa Arranz E

المصدر: Neoplasia (New York, N.Y.) [Neoplasia] 2012 Dec; Vol. 14 (12), pp. 1144-52.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print Cited Medium: Internet ISSN: 1476-5586 (Electronic) Linking ISSN: 14765586 NLM ISO Abbreviation: Neoplasia Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carcinoma, Renal Cell/*blood , Indoles/*therapeutic use , Kidney Neoplasms/*blood , MicroRNAs/*blood , Pyrroles/*therapeutic use, Aged ; Aged, 80 and over ; Area Under Curve ; Carcinoma, Renal Cell/drug therapy ; Carcinoma, Renal Cell/genetics ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Kidney Neoplasms/drug therapy ; Kidney Neoplasms/genetics ; Logistic Models ; Male ; Middle Aged ; Oligonucleotide Array Sequence Analysis ; Predictive Value of Tests ; Prospective Studies ; ROC Curve ; Statistics, Nonparametric ; Sunitinib ; Survival Analysis ; Treatment Outcome

المؤلفون: Grande E; Gastrointestinal and Early Drug Development Unit, Servicio de Oncología Médica, Hospital Ramón y Cajal, Carretera de Colmenar Viejo Km. 9.100, 28034, Madrid, Spain. egrande@oncologiahrc.com, Bolós MV, Arriola E

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2011 Apr; Vol. 10 (4), pp. 569-79.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Enzyme Inhibitors/*therapeutic use , Neoplasms/*drug therapy , Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors, Anaplastic Lymphoma Kinase ; Gene Amplification ; Humans ; Mutation ; Neoplasms/enzymology ; Neoplasms/genetics ; Oncogene Proteins, Fusion/antagonists & inhibitors ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/metabolism ; Pyrimidines/therapeutic use ; Receptor Protein-Tyrosine Kinases/genetics ; Receptor Protein-Tyrosine Kinases/metabolism

المؤلفون: Aparicio LM; UDC, Medical Department, A Coruña, Spain., Villaamil VM, Gallego GA, Caínzos IS, Campelo RG, Rubira LV, Estévez SV, Mateos LL, Perez JL, Vázquez MR, Calvo OF, Bolós MV

المصدر: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2011 Mar-Apr; Vol. 8 (2), pp. 93-101.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 101188791 Publication Model: Print Cited Medium: Internet ISSN: 1790-6245 (Electronic) Linking ISSN: 11096535 NLM ISO Abbreviation: Cancer Genomics Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Ligands*, Carcinoma, Renal Cell/*metabolism , Kidney Neoplasms/*metabolism , Receptors, Notch/*biosynthesis, Adaptor Proteins, Signal Transducing ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/biosynthesis ; Calcium-Binding Proteins/biosynthesis ; Carcinoma, Renal Cell/pathology ; Cell Line, Tumor ; Female ; Humans ; Immunohistochemistry ; Intercellular Signaling Peptides and Proteins/biosynthesis ; Intracellular Signaling Peptides and Proteins ; Kidney Neoplasms/pathology ; Male ; Membrane Proteins/biosynthesis ; Middle Aged ; Prognosis ; Proteomics/methods ; Proto-Oncogene Proteins/biosynthesis ; Receptor, Notch1/biosynthesis ; Receptor, Notch2/biosynthesis ; Receptor, Notch3 ; Receptor, Notch4 ; Serrate-Jagged Proteins ; Tissue Array Analysis

المؤلفون: Aparicio LM; A Coruña University Hospital, 15006 A Coruña, Spain. luis.m.anton.aparicio@sergas.es., Villaamil VM, Calvo MB, Rubira LV, Rois JM, Valladares-Ayerbes M, Campelo RG, Bolós MV, Pulido EG

المصدر: Molecular medicine reports [Mol Med Rep] 2010 Jul-Aug; Vol. 3 (4), pp. 575-80.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print Cited Medium: Internet ISSN: 1791-3004 (Electronic) Linking ISSN: 17912997 NLM ISO Abbreviation: Mol Med Rep Subsets: PubMed not MEDLINE